2025-2034 Clinical Biomarkers Market Roadmap: Insights for Competitive Advantage

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Clinical Biomarkers Market Size By 2025?
In recent years, the size of the clinical biomarkers market has shown robust growth. The market which stands at $30.78 billion in 2024 is projected to rise to $33.85 billion in 2025, with a compound annual growth rate (CAGR) of 10.0%. The growth observed in the previous period can be credited to the increased occurrence of chronic diseases, the emphasis on personalized medicine and targeted therapies, advancements in drug development and clinical trials, as well as support from regulatory bodies and funding.

How Big Is the Clinical Biomarkers Market Size Expected to Grow by 2029?
The size of the clinical biomarkers market is projected to experience substantial growth in the coming years, escalating to $52.8 billion by 2029 with a compound annual growth rate of 11.8%. This growth during the predicted period can be ascribed to numerous factors including the expansion of companion diagnostics, emphasis on early diagnosis and preventative measures against diseases, enhanced application in precision oncology and neurodegenerative diseases, and an increase in infectious diseases. During the forecast period, significant trends such as advancements in AI-powered biomarker discovery, incorporation of machine learning, integration of multi-omics, technological breakthroughs, and partnerships among key players are expected to surface.

View the full report here:
https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Which Key Market Drivers Powering Clinical Biomarkers Market Expansion and Growth?
The escalating prevalence of cancer is likely to boost the expansion of the clinical biomarker market. The term "cancer" refers to a collection of disorders characterised by abnormal cellular growth and division, which could potentially intrude on and damage healthy tissues within the body. Clinical biomarkers are integral to cancer prevention because they assist in early recognition, risk evaluation, and surveillance of individuals vulnerable to contracting cancer. For example, Cancer Research UK, a UK-based entity dedicated to cancer research, predicts a surge in new kidney cancer cases from approximately 16,300 to around 21,900 between 2023-2025, up until 2038-2040 - a 15% escalation during this timeframe. Consequently, the rising prevalence of cancer is powering the progress of the clinical biomarker market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12670&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Clinical Biomarkers Market?
The rise of technological innovations is an emerging trend in the clinical biomarker market. Prominent players in this space are consistently exploring innovative solutions to secure their market position. For example, VeraBIND, a novel technology used for Biomarker Isolation and N-enrichment for Detection, was launched by Veravas Inc., a US-based medicinal products manufacturer, in June 2023. The technology introduces a unique and comprehensive method that amplifies the accuracy of biomarker identification and decreases the chance of receiving false positives or negatives in varied sample types. Adopting this innovation in clinical laboratories can augment diagnostic procedures and foster early detection of diseases, enabling immediate and specific interventions. Furthermore, VeraBIND technology expedites the process of assay development, ensuring precision and uniformity in research, clinical trials, and diagnostic screenings.

What Are the Emerging Segments in the Clinical Biomarkers Market?
The clinical biomarkers market covered in this report is segmented -

1) By Offering: Product, Service
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies
3) By Clinical Area: Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Immunological Biomarker, Non-Invasive Prenatal Testing, Other Clinical Areas
4) By Application: Clinical Diagnostic, Translational Research
5) By End User: Contract Research Organizations (CROs), Research And Academic Laboratories, Biopharmaceutical And Biotech Companies, Diagnostic Centers, Other End Users

Subsegments:
1) By Product: Diagnostic Kits, Reagents, Assay Kits, Instruments
2) By Service: Biomarker Discovery Services, Analytical Services, Clinical Trial Services, Data Analysis Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12670&type=smp

Who Are the Global Leaders in the Clinical Biomarkers Market?
Major companies operating in the clinical biomarkers market include Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific, Agilent Technologies Inc., Epigenomics AG, Grifols S.A., Illumina Inc., BioMerieux SA., Charles River Laboratories International Inc., PerkinElmer Inc., Sartorius AG, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Luminex Corporation, Veracyte Inc., Centogene N.V., NanoString Technologies Inc., Enzo Biochem Inc., Biocartis Group NV, Agendia Inc., Siemens Healthcare Private Limited.

Which are the Top Profitable Regional Markets for the Clinical Biomarkers Industry?
North America was the largest region in the clinical biomakers market in 2024. The regions covered in the clinical biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12670

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.